Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: A Natural History Study In Chinese Male Patients With Duchenne Muscular Dystrophy [NA]

View source ↗

Summary

Pfizer-sponsored natural history study in Chinese male patients with Duchenne muscular dystrophy has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Pfizer | Conditions: Duchenne Muscular Dystrophy | NA | Status: COMPLETED | Results posted: 2024-09-19